ClinicalTrials.govpublic full text
Open-Label Rollover Study of Levosimendan in PH-HFpEF Patients
hypertension pulmonary secondary heart failure, right sided heart failure with normal ejection fraction, heart failure with normal ejection fraction
ClinicalTrials.gov
Show glossary
Search for terms
Hide glossary
Study record managers: refer to the
Data Element Definitions
if submitting registration or results information.
Record · ID 121515 · SHA-256 e5bfa50054351e7a
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.